HIV in Lebanon: Reasons for Testing, Engagement in Care, and Outcomes in Patients with Newly Diagnosed HIV Infections
AbstractLittle is known about clinical presentation and cascade of care among patients living with HIV (PLWH) in Beirut, Lebanon. The study aims to examine the reasons for HIV testing and to evaluate the clinical characteristics of, predictors of advanced HIV stage at presentation in, and rates of ART initiation, retention in care, and viral load suppression among PLWH in Lebanon. We conducted a retrospective study of PLWH presenting to a tertiary-care centre-affiliated outpatient clinic from 2008 to 2016 with new HIV infection diagnoses. We identified a total of 423 patients: 89% were men, 55% were 30 –50 years old, and 58% self-identified as men who have sex with men. About 35% of the patients had concurrent sexually transmitted diseases at the time of HIV diagnosis. Thirty percent of infection cases were identified by provider-initiated HIV testing, 36% of cases were identified by patient-in itiated testing, and 34% of patients underwent testing for screening purposes. The proportion of individuals presenting with advanced HIV disease decreased from 40% in 2008–2009 to 24% in 2014–2015. Age older than 50 years and identification of HIV by a medical provider were independent predict ors of advanced HIV infection at presentation. Among patients having indications for treatment (n = 253), 239 (94%) were prescribed antiretroviral therapy, and 147 (58%) had evidence of viral suppression at 1 year. Furthermore, 266 patients (63%) we...
[The Conversation Africa] An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was disappointing, but the search for an effective HIV vaccine continues. Anatoli Kamali speaks to The Conversation Africa's Ina Skosana about other developments in the field.
[This Day] The federal government has said it may as well deploy HIV drug, Kaletra, to treat the Coronavirus in the event that it gets to Nigeria.
[The Conversation Africa] HIV and AIDS are still global health problems and sub-Saharan Africa remains the most affected region. Globally, around 770,000 people died from AIDS-related conditions in 2018, 160,000 of them in West and Central Africa.
[Nation] When is was announced that the trials of HVTN 70, an experimental vaccine that could protect people against HIV, the virus that causes Aids, had been cancelled for non-efficacy, Ms Inviolata Mmbavi was disappointed.
[WHO] Uganda commences field data collection to inform the Population Based HIV Impact Assessment Survey (UPHIA 2020)
BACKGROUND/OBJECTIVE: STIs and HIV/AIDS are an important public health problem, transmitted by risky sex behaviours. In this context, it is necessary to identify protective factors, of those behaviours, as sexual self-concept. Sexual self-concept is a mult...
[New Zimbabwe] A Chiredzi based anti-HIV sex workers peer educators group says it has registered over 1 000 women plying their trade in the red light districts and has further discouraged the promiscuous lot from having a permanent boyfriend for fear of spreading HIV through unprotected sex.
[Unicef] Dakar -Joint UNFAO, UNICEF and WFP press release
[UCT] The early abandonment of HIV vaccine study HVTN 702 (also known as Uhambo) in South Africa for failing to prevent infections is a huge setback in the quest to find an HIV vaccine. However, this will not deter scientists, said the University of Cape Town's (UCT) Professor Linda-Gail Bekker.
[This is Africa] Google has honoured the late South African child AIDS activist Nkosi Johnson with a Google doodle.